非气动装置与四种间歇充气加压装置对股总静脉血流动力学影响的比较
本研究比较新型非气动MAC系统与四种现有间歇充气加压装置在外部机械压迫下对股总静脉血流增强的效果。20名受试者的多普勒超声测量显示,MAC系统在三个比较中峰值流速较基线显著增加,且达到峰值流速的时间显著更快(P < .001),并且在所有BMI组中唯一达到至少三倍基线峰值流速的目标。MAC系统在行走后100%测量中移动小于2.5 cm,75%测量无移动。
要点
- MAC系统在三个比较中峰值流速较基线显著增加(Kendall SCD 700 P=.02;ActiveCare+S.F.T. P=.003;Circul8 P<.001)。
- MAC系统达到峰值流速的时间显著快于其他装置(P < .001)。
- MAC系统是唯一在所有BMI组中均达到至少三倍基线峰值流速目标的装置。
核心结论
- MAC系统是一种移动设备,行走时保持原位,与本研究中的其他三种装置相比,在所需范围内提供更一致的外部机械压迫。
研究设计与样本
- 研究纳入20名受试者,年龄均值±标准差50.5±16.2岁,BMI均值±标准差26±5.5 kg/m2,男性25%,女性75%,右小腿周长均值±标准差37.2±5.5 cm。
- 由注册血管技师直接对右股总静脉进行多普勒超声测量,计算峰值流速和达到峰值的时间。
- 仅MAC系统组要求受试者穿戴系统行走至少500步,然后检查是否滑移;腿部尺寸使用非接触式Sigvaris Legreader XT5测量。
主要发现
- 与基线相比,MAC系统在三个比较中峰值流速显著更高:Kendall SCD 700(P = .02)、ActiveCare+S.F.T.(P = .003)、Circul8(P < .001)。
- Arjo Huntleigh Flowtron ACS900的峰值流速测量变异性(标准差3.4 cm/s)大于MAC系统(标准差1.9 cm/s),但差异无统计学意义。
- MAC系统达到峰值流速的时间显著快于比较装置(P < .001)。
- MAC系统是唯一在每个BMI组中均达到至少三倍基线峰值流速目标的装置。
- MAC系统在行走后100%的测量中移动小于2.5 cm,其中75%的测量显示无移动。
关键数值与推荐
- MAC系统达到峰值流速的时间显著快于比较装置(P < .001)。
- MAC系统在行走后100%的测量中移动小于2.5 cm,75%的测量无移动。
临床怎么用
- MAC系统作为一种移动设备,可在行走时保持原位并提供一致的外部机械压迫,可能有助于静脉血栓栓塞预防。
局限性
- MAC装置尚未商业化,本研究是静脉血栓栓塞预防临床研究的前期研究。
- 样本量较小(20名受试者),且仅测量了右股总静脉。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The purpose of the present study was to compare common femoral vein blood flow enhancement during external mechanical compression using the novel, nonpneumatic Recovery Force Health Movement and Compressions (MAC) System (Recovery Force USA, Fishers, Ind), and four currently available intermittent pneumatic compression devices. METHODS: The MAC device was compared with the Kendall SCD 700 (Cardinal Health, Dublin, Ohio), Arjo Huntleigh Flowtron ACS900 (Arjo, Malmö, Sweden), ActiveCare+S.F.T. (Zimmer Biomet, Warsaw, Ind), and Circul8 (Ortho8, Rocklin, Calif). Doppler ultrasound measurements for each device were directly obtained from the right common femoral vein by a registered vascular technologist. The peak flow velocity and the time taken to reach the peak were calculated. For the MAC system only, the subjects were asked to walk a minimum of 500 steps while wearing the system, which was then checked for slippage. Leg size measurements were obtained using the noncontact Sigvaris Legreader XT5 (Vialis Ortopedia, Turin, Italy). The MAC device is not yet commercially available, and the present study was a prequel to clinical studies of venous thromboembolism prevention. RESULTS: We recruited a broad range of 20 subjects who varied in age (mean ± standard deviation [SD], 50.5 ± 16.2 years), body mass index (mean ± SD, 26 ± 5.5 kg/m2), gender (male, 25%; female, 75%), and right calf circumference (mean ± SD, 37.2 ± 5.5 cm). The peak flow velocity compared with the baseline measurements was significantly greater for the Recovery Force Health MAC System for three (Kendall SCD 700, P = .02; ActiveCare+S.F.T., P = .003; Circul8, P < .001) of the four comparisons. Although the difference was not significant, the Arjo Huntleigh Flowtron ACS900 (SD, 3.4 cm/s) had more measurement variability in the peak flow velocity compared with baseline than did the MAC System (SD, 1.9 cm/s). The MAC had a significantly (P < .001) faster rise time to peak flow compared with the comparison devices. It was the only device to achieve the target peak flow velocity over baseline of at least three times in every body mass index group. Finally, the MAC System met the goal of <2.5 cm of movement after ambulation in 100% of the measurements, with 75% of the measurements showing no movement. CONCLUSIONS: The MAC System is a mobile device that remained in place during ambulation and provided more consistent external mechanical compression in the desired range compared with the other three devices included in the present study.
引用
- Labropoulos N, Giuliano KK, Tafur AJ, et al. Comparison of a nonpneumatic device to four currently available intermittent pneumatic compression devices on common femoral blood flow dynamics. J Vasc Surg Venous Lymphat Disord. 2021. PMID: 33540132. doi:10.1016/j.jvsv.2021.01.008
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。